Pharmacotherapeutic Options for Bipolar Depression
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Pharmacotherapeutic Options for Bipolar Depression
-
Narrated by:
-
By:
About this listen
A patient with a history of rapid-cycling bipolar disorder presents for evaluation of her current, profound depressive symptoms. The patient has been maintained for the last two years on valproic acid and quetiapine, but now a major depressive episode has occurred and the patient is reporting passive suicidal ideation.
Concerned that the suicidal ideation may progress, the PMHNP consider which of the following pharmacotherapeutic options?
A. Cariprazine
B. Lumateperone
C. Aripiprazole
D. Lithium
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.